Field comparison of OraQuick® ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia

BackgroundZambia’s national HIV testing algorithm specifies use of two rapid blood based antibody assays, Determine®HIV-1/2 (Inverness Medical) and if positive then Uni-GoldTM Recombigen HIV-1/2 (Trinity Biotech). Little is known about the performance of oral fluid based HIV testing in Zambia. The aims of this study are two-fold: 1) to compare the diagnostic accuracy (sensitivity and specificity) under field conditions of the OraQuick® ADVANCE® Rapid HIV-1/2 (OraSure Technologies, Inc.) to two blood-based rapid antibody tests currently in use in the Zambia National Algorithm, and 2) to perform a cost analysis of large-scale field testing employing the OraQuick®.MethodsThis was a operational retrospective research of HIV testing and questionnaire data collected in 2010 as part of the ZAMSTAR (Zambia South Africa TB and AIDS reduction) study. Randomly sampled individuals in twelve communities were tested consecutively with OraQuick® test using oral fluid versus two blood-based rapid HIV tests, Determine® and Uni-GoldTM. A cost analysis of four algorithms from health systems perspective were performed: 1) Determine® and if positive, then Uni-GoldTM (Determine®/Uni-GoldTM); based on current algorithm, 2) Determine® and if positive, then OraQuick® (Determine®/OraQuick®), 3) OraQuick® and if positive, then Determine® (OraQuick®/Determine®), 4) OraQuick® and if positive, then Uni-GoldTM (OraQuick®/Uni-GoldTM). This information was then used to construct a model using a hypothetical population of 5,000 persons with varying prevalence of HIV infection from 1–30%.Results4,458 participants received both a Determine® and OraQuick® test. The sensitivity and specificity of the OraQuick® test were 98.7 (95%CI, 97.5–99.4) and 99.8 (95%CI, 99.6–99.9), respectively when compared to HIV positive serostatus. The average unit costs per algorithm were US$3.76, US$4.03, US$7.35, and US$7.67 for Determine®/Uni-GoldTM, Determine®/OraQuick®, OraQuick®/Determine®, and OraQuick®/Uni-GoldTM, respectively, for an HIV prevalence of 15%.ConclusionsAn alternative HIV testing algorithm could include OraQuick® test which had a high sensitivity and specificity. The current Determine®/Uni-GoldTM testing algorithm is the least expensive when compared to Determine®/OraQuick®, OraQuick®/Determine®, and OraQuick®/Uni-GoldTM in the Zambian setting. From our field experience, oral fluid based testing offers many advantages over blood-based testing, especially with self testing on the horizon.

[1]  C. Scully,et al.  HIV topic update: oro-genital transmission of HIV. , 2008, Oral diseases.

[2]  J. Nelson,et al.  Comparison of Two Rapid Human Immunodeficiency Virus (HIV) Assays, Determine HIV-1/2 and OraQuick Advance Rapid HIV-1/2, for Detection of Recent HIV Seroconversion , 2008, Journal of Clinical Microbiology.

[3]  S. Peel,et al.  Large-Scale Human Immunodeficiency Virus Rapid Test Evaluation in a Low-Prevalence Ugandan Blood Bank Population , 2007, Journal of Clinical Microbiology.

[4]  Peter Piot,et al.  Joint United Nations Program on HIV/AIDS (UNAIDS) , 1997 .

[5]  Jeffrey L. Greenwald,et al.  Factors Associated with False-Positive Results from Fingerstick OraQuick ADVANCE Rapid HIV 1/2 Antibody Test , 2012, Journal of the International Association of Physicians in AIDS Care.

[6]  James Mudzori,et al.  Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe. , 2009, AIDS patient care and STDs.

[7]  Shandir Ramlagan,et al.  South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey, 2005 , 2008 .

[8]  S. Asch,et al.  Cost of OraQuick oral fluid rapid HIV testing at 35 community clinics and community-based organizations in the USA , 2009, AIDS care.

[9]  C. Delaugerre,et al.  Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting , 2010, PloS one.

[10]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[11]  E. Lyamuya,et al.  Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania , 2009, BMC infectious diseases.

[12]  Alice Mao,et al.  Acute Dengue fever causes false-positive reactivity in OraQuick rapid HIV-1/2 antibody test. , 2010, Journal of acquired immune deficiency syndromes.

[13]  L. Simbayi,et al.  Nelson Mandela / HSRC study of HIV/AIDS. South African national HIV prevalence behavioural risks and mass media. Household survey 2002. , 2002 .

[14]  Scaling up priority HIV / AIDS interventions in the health sector JUNE 2008 , 2008 .

[15]  C. Luo,et al.  Rapid HIV testing and counseling for voluntary testing centers in Africa. , 1997, AIDS.

[16]  Thomas Rehle,et al.  South African national HIV prevalence, incidence, behaviour and communication survey, 2008: a turning tide among teenagers? , 2009 .

[17]  B. Richardson,et al.  Validation of Rapid HIV Antibody Tests in 5 African Countries , 2010, Journal of the International Association of Physicians in AIDS Care.

[18]  Lawrence Joseph,et al.  Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[19]  T. Coates,et al.  Removing Barriers to Knowing HIV Status: Same-Day Mobile HIV Testing in Zimbabwe , 2006, Journal of acquired immune deficiency syndromes.

[20]  J. Cano,et al.  Oral transmission of HIV, reality or fiction? An update. , 2006, Oral diseases.

[21]  N. French,et al.  The Uptake and Accuracy of Oral Kits for HIV Self-Testing in High HIV Prevalence Setting: A Cross-Sectional Feasibility Study in Blantyre, Malawi , 2011, PLoS medicine.

[22]  R. Hayes,et al.  ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial , 2008, Trials.